Initial ribociclib plus endocrine therapy for HR+/HER2- advanced breast cancer in pre- and postmenopausal Chinese
Zhimin Shao1, Zhongsheng Tong2, Qiang Liu3
1Fudan University Shanghai Cancer Center, Shanghai, China.
Cancer Medicine
|August 13, 2024
Abstract
No abstract available in PubMed .


